• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE ENDOTAK RELIANCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE ENDOTAK RELIANCE Back to Search Results
Model Number 0295
Device Problems Failure to Capture (1081); Pocket Stimulation (1463); Capturing Problem (2891); Device Dislodged or Dislocated (2923); Material Integrity Problem (2978)
Patient Problem Muscle Stimulation (1412)
Event Date 10/26/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.The rv lead passed electrical testing.It was found that the helix mechanism failed to operate, most likely due to dried body fluid/blood in the mechanism.No damages were noted at the lead tip or helix that would have contributed to the dislodgement.
 
Event Description
Boston scientific received information that this patient experienced diaphragmatic stimulation and their right ventricular (rv) lead exhibited loss of capture.No asystole was observed.The lead had normal sensing and impedance measurements were within normal range.A revision procedure was performed due to concern of exit block.While repositioning the lead, the physician attempted to retract the helix however was unsuccessful and the lead dislodged.The physician then elected to fully extract the lead.Once removed, the physician again unsuccessfully attempted to retract the helix.The lead was returned for analysis and another rv lead was implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
--.
 
Event Description
Boston scientific received information that this patient experienced diaphragmatic stimulation and their right ventricular (rv) lead exhibited high pacing threshold measurements and loss of capture.The patient never required rv pacing, and no asystole was observed.The lead had normal sensing and impedance measurements were within normal range.A micro-dislodgement was suspected but not confirmed.A revision procedure was performed due to concern of exit block.While repositioning the lead, the physician attempted to retract the helix however was unsuccessful and the lead dislodged.The physician then elected to fully extract the lead.Once removed, the physician again unsuccessfully attempted to retract the helix.The lead was returned for analysis and another rv lead was implanted.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key5420524
MDR Text Key37836504
Report Number2124215-2016-02503
Device Sequence Number1
Product Code NVY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup
Report Date 10/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/17/2015
Device Model Number0295
Other Device ID NumberRELIANCE 4-SITE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/03/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 10/30/2015
Initial Date FDA Received02/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/04/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/17/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age57 YR
-
-